The vast majority of lymphoma patients treated firstline with CHOP and R-CHOP are missing out on vital cardiac monitoring as recommended by international guidelines, a review has found. The systematic review and meta-analysis of 137 studies and over 21,000 patients published in Lancet Haematology found that despite the well established association of doxorubicin with left ...
Include a cardiologist in lymphoma teams: review
By Nicola Garrett
10 Mar 2020